Total Payments
$14,039
2024 Payments
$1,838
Companies
59
Transactions
1,127
Medicare Patients
7,400
Medicare Billing
$665,209
Payment Breakdown by Category
Food & Beverage$13,903 (99.0%)
Education$102.94 (0.7%)
Other$33.31 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,903 | 1,121 | 99.0% |
| Education | $102.94 | 4 | 0.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $33.31 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,834 | 118 | $0 (2024) |
| Novo Nordisk Inc | $1,833 | 178 | $0 (2024) |
| PFIZER INC. | $1,443 | 196 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,237 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,104 | 106 | $0 (2024) |
| Lilly USA, LLC | $755.87 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $578.52 | 48 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $513.22 | 38 | $0 (2023) |
| Merck Sharp & Dohme LLC | $499.14 | 34 | $0 (2024) |
| Amgen Inc. | $397.56 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,838 | 101 | ABBVIE INC. ($377.75) |
| 2023 | $1,876 | 117 | ABBVIE INC. ($680.24) |
| 2022 | $1,990 | 145 | ABBVIE INC. ($308.84) |
| 2021 | $1,831 | 126 | AbbVie Inc. ($353.34) |
| 2020 | $1,549 | 125 | Novo Nordisk Inc ($210.80) |
| 2019 | $1,424 | 138 | PFIZER INC. ($259.73) |
| 2018 | $1,771 | 182 | PFIZER INC. ($307.00) |
| 2017 | $1,760 | 193 | PFIZER INC. ($292.85) |
All Payment Transactions
1,127 individual payment records from CMS Open Payments — Page 1 of 46
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: VACCINE | ||||||
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: PAIN | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/20/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.15 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: PAIN | ||||||
| 11/08/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: PAIN | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $1.86 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: VACCINES | ||||||
| 10/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $32.74 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Obesity | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Respiratory | ||||||
| 10/02/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: VACCINE | ||||||
| 09/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Central Nervous System | ||||||
| 09/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.06 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.85 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Bone Health | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,854 | 4,243 | $328,951 | $176,227 |
| 2022 | 26 | 1,868 | 4,312 | $316,451 | $163,336 |
| 2021 | 31 | 1,894 | 4,595 | $307,317 | $159,614 |
| 2020 | 22 | 1,784 | 5,083 | $316,787 | $166,033 |
Total Patients
7,400
Total Services
18,233
Medicare Billing
$665,209
Procedure Codes
105
All Medicare Procedures & Services
105 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 254 | 517 | $88,924 | $37,559 | 42.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 16 | 1,620 | $59,940 | $29,531 | 49.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 86 | 86 | $30,960 | $24,300 | 78.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 186 | 186 | $40,734 | $23,319 | 57.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 101 | 163 | $39,935 | $19,569 | 49.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 119 | 121 | $11,011 | $8,693 | 79.0% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 41 | 41 | $6,970 | $5,268 | 75.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 19 | $6,460 | $3,883 | 60.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 124 | 126 | $5,166 | $3,711 | 71.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 197 | 197 | $5,122 | $3,497 | 68.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 186 | 186 | $4,650 | $3,302 | 71.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 83 | 83 | $2,407 | $2,359 | 98.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 171 | 256 | $3,072 | $2,150 | 70.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $3,147 | $2,092 | 66.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 36 | $5,125 | $1,640 | 32.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 41 | 41 | $2,132 | $1,610 | 75.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 121 | $4,235 | $1,189 | 28.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 14 | 14 | $1,820 | $631.69 | 34.7% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 15 | 15 | $780.00 | $589.05 | 75.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 11 | 11 | $1,782 | $553.17 | 31.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 29 | 30 | $1,710 | $278.50 | 16.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 33 | 267 | $1,335 | $198.42 | 14.9% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 17 | 19 | $520.00 | $173.88 | 33.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 21 | 24 | $216.00 | $52.80 | 24.4% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 12 | 12 | $96.00 | $38.83 | 40.4% |
About Dr. John Lunsford, M.D
Dr. John Lunsford, M.D is a Family Medicine healthcare provider based in Hanover, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1013916899.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Lunsford, M.D has received a total of $14,039 in payments from pharmaceutical and medical device companies, with $1,838 received in 2024. These payments were reported across 1,127 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($13,903).
As a Medicare-enrolled provider, Lunsford has provided services to 7,400 Medicare beneficiaries, totaling 18,233 services with total Medicare billing of $665,209. Data is available for 4 years (2020–2023), covering 105 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hanover, PA
- Active Since 07/14/2005
- Last Updated 10/12/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1013916899
Products in Payments
- XIFAXAN (Drug) $612.30
- Ozempic (Drug) $600.06
- FARXIGA (Drug) $577.29
- VRAYLAR (Drug) $552.92
- CHANTIX (Drug) $524.18
- TRELEGY ELLIPTA (Drug) $439.08
- UBRELVY (Drug) $424.67
- BREZTRI (Drug) $372.95
- BOTOX (Biological) $363.48
- JARDIANCE (Drug) $352.55
- NURTEC ODT (Drug) $349.30
- ELIQUIS (Drug) $327.01
- TRULICITY (Drug) $327.00
- Wegovy (Drug) $269.39
- Rybelsus (Drug) $254.83
- LYRICA (Drug) $254.33
- SHINGRIX (Biological) $251.46
- XARELTO (Drug) $237.63
- Victoza (Drug) $228.56
- Saxenda (Drug) $213.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hanover
Surender Singh, Md, MD
Family Medicine — Payments: $18,727
Family Medicine $18,727
Dr. Maureen Eisenberg, D.o, D.O
Family Medicine — Payments: $11,821
Family Medicine $11,821
Dr. Jennifer Rein, M.d, M.D
Family Medicine — Payments: $9,338
Family Medicine $9,338
Dr. Robert Henke, M.d, M.D
Family Medicine — Payments: $6,082
Family Medicine $6,082
Esther Ajjarapu, Md, MD
Family Medicine — Payments: $4,657
Family Medicine $4,657
Jonathan Mccoy, Md, MD
Family Medicine — Payments: $4,097
Family Medicine $4,097